Scoring systems improve timing of cell transplant for MDS patients

06/27/2013 | MDSBeacon.com

The use of prognosis scoring systems to time donor stem cell transplantation may extend the lives of patients treated for myelodysplastic syndromes, according to a study in the American Journal of Hematology. Researchers in Italy found that delayed transplantation may be better for patients whose early illness is considered very low- or low-risk by the World Health Organization classification-based Prognostic Scoring System and low-risk by the International Prognostic Scoring System.

View Full Article in:

MDSBeacon.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Deputy Director, Marketing
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Director of Operations - GBS
Mayo Clinic
MN
Director of Actuarial Services, Government Programs
PacificSource
OR
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC